Filing Details
- Accession Number:
- 0001209191-17-053670
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-22 08:27:50
- Reporting Period:
- 2017-09-21
- Accepted Time:
- 2017-09-22 08:27:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
883107 | Nanophase Technologies Corp | NANX | Miscellaneous Primary Metal Products (3390) | 363687863 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1173970 | Janet R Whitmore | 1319 Marquette Drive Romeoville IL 60446 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-09-21 | 5,200 | $0.65 | 1,243,507 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 135,584 | Indirect | By Daughter |
Common Stock | 102,909 | Indirect | By Son |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $1.36 | 2012-01-31 | 2021-01-31 | 10,000 | 10,000 | Direct |
Common Stock | Deferred Common Stock | $0.00 | 2,000 | 20,030 | Direct | ||
Common Stock | Stock Option (right to buy) | $0.30 | 2013-08-07 | 2022-08-07 | 10,000 | 10,000 | Direct |
Common Stock | Stock Option (right to buy) | $0.42 | 2014-02-14 | 2023-02-14 | 10,000 | 10,000 | Direct |
Common Stock | Stock Option (right to buy) | $0.52 | 2015-02-13 | 2024-02-13 | 10,000 | 10,000 | Direct |
Common Stock | Stock Option (right to buy) | $0.44 | 2016-02-18 | 2025-02-18 | 9,000 | 9,000 | Direct |
Common Stock | Stock Option (right to buy) | $0.42 | 2017-02-23 | 2026-02-23 | 8,100 | 8,100 | Direct |
Common Stock | Stock Option (right to buy) | $0.90 | 2016-11-17 | 2026-11-17 | 2,000 | 2,000 | Direct |
Common Stock | Stock Option (right to buy) | $1.05 | 2016-11-17 | 2026-11-17 | 2,000 | 2,000 | Direct |
Common Stock | Stock Option (right to buy) | $1.18 | 2016-11-17 | 2026-11-17 | 2,000 | 2,000 | Direct |
Common Stock | Stock Option (right to buy) | $0.84 | 2016-11-17 | 2026-11-17 | 2,000 | 2,000 | Direct |
Common Stock | Stock Option (right to buy) | $1.85 | 2016-11-17 | 2026-11-17 | 2,000 | 2,000 | Direct |
Common Stock | Stock Option (right to buy) | $1.10 | 2016-11-17 | 2026-11-17 | 2,000 | 2,000 | Direct |
Common Stock | Stock Option (right to buy) | $0.99 | 2016-11-17 | 2026-11-17 | 2,000 | 2,000 | Direct |
Common Stock | Stock Option (right to buy) | $0.68 | 2018-02-21 | 2027-02-21 | 10,000 | 10,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-01-31 | 10,000 | 10,000 | Direct |
2,000 | 20,030 | Direct | |
2022-08-07 | 10,000 | 10,000 | Direct |
2023-02-14 | 10,000 | 10,000 | Direct |
2024-02-13 | 10,000 | 10,000 | Direct |
2025-02-18 | 9,000 | 9,000 | Direct |
2026-02-23 | 8,100 | 8,100 | Direct |
2026-11-17 | 2,000 | 2,000 | Direct |
2026-11-17 | 2,000 | 2,000 | Direct |
2026-11-17 | 2,000 | 2,000 | Direct |
2026-11-17 | 2,000 | 2,000 | Direct |
2026-11-17 | 2,000 | 2,000 | Direct |
2026-11-17 | 2,000 | 2,000 | Direct |
2026-11-17 | 2,000 | 2,000 | Direct |
2027-02-21 | 10,000 | 10,000 | Direct |
Footnotes
- Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
- Each share of deferred common stock represents a right to receive one share of common stock.
- The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
- Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
- Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.
- The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99.